Preventing Cardiac Complications of COVID-19 Disease with Early Acute Coronary Syndrome Therapy (C19-ACS)
This randomised controlled trial aims to determine whether acute coronary syndromes are occurring during COVID-19 disease and not being adequately diagnosed and treated.
| Imperial PI | Professor Prapa Kanagaratnam Professor Darrel Francis |
| Trial Sponsor | Imperial College London |
| Study type | Interventional |
| Study status | In recruitment |
Find out more about this study here.
App to inform & enrol patients Study Documents Explainer video